Renal disease progression. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Kidney Kidney Glomerulus Cell Line, Tumor Kidney Tubules Cells, Cultured CD4-Positive T-Lymphocytes Podocytes Cell Line Glomerular Mesangium Brain Tumor Cells, Cultured Glomerular Basement Membrane T-Lymphocytes Kidney Tubules, Proximal Macrophages CD8-Positive T-Lymphocytes Epithelial Cells

Organisms11

HIV-1 Mice, Transgenic Mice, Inbred C57BL Mice, Knockout Simian immunodeficiency virus Macaca mulatta Mice, Inbred NZB Mice, Inbred MRL lpr Mice, Inbred BALB C Rats, Sprague-Dawley Mice, Nude

Diseases78

Disease Progression Kidney Diseases Proteinuria Kidney Failure, Chronic Diabetic Nephropathies Disease Models, Animal HIV Infections Glomerulonephritis Renal Insufficiency, Chronic Chronic Disease Albuminuria Lupus Nephritis Glomerulosclerosis, Focal Segmental Prostatic Neoplasms Nephritis Neoplasm Metastasis Nephritis, Interstitial Acquired Immunodeficiency Syndrome Renal Insufficiency AIDS-Associated Nephropathy Glomerulonephritis, IGA Hypertension, Renal Nephrosclerosis Fibrosis Hypertension Polycystic Kidney, Autosomal Dominant Uremia Polycystic Kidney Diseases Breast Neoplasms Amyotrophic Lateral Sclerosis Cardiovascular Diseases Neoplasms Neoplasm Invasiveness Inflammation Nephrotic Syndrome Lung Neoplasms Diabetes Mellitus, Type 2 Kidney Neoplasms Anemia Kidney Diseases, Cystic Adenocarcinoma Recurrence Lupus Erythematosus, Systemic Simian Acquired Immunodeficiency Syndrome Genetic Predisposition to Disease Melanoma Glomerulonephritis, Membranous Diabetes Mellitus, Type 1 Glomerulonephritis, Membranoproliferative Cell Transformation, Neoplastic Calcinosis Alzheimer Disease Acute Kidney Injury Neoplasm Recurrence, Local Skin Neoplasms Nephritis, Hereditary Liver Neoplasms Liver Cirrhosis Carcinoma, Renal Cell HIV Seropositivity Colorectal Neoplasms Multiple Myeloma Atherosclerosis Huntington Disease Calciphylaxis Diabetes Mellitus Leukemia, Lymphocytic, Chronic, B-Cell Brain Neoplasms Atrophy Carcinoma Neovascularization, Pathologic Diabetes Complications Urinary Bladder Neoplasms Precancerous Conditions Hematuria Bone Neoplasms Parkinson Disease Multiple Sclerosis

Chemicals and Drugs40

Angiotensin-Converting Enzyme Inhibitors Creatinine Biological Markers Antineoplastic Agents Tumor Markers, Biological RNA, Messenger Antihypertensive Agents Antibodies, Monoclonal Immunosuppressive Agents Receptors, CCR5 Cytokines Transforming Growth Factor beta Antibodies, Monoclonal, Humanized Autoantibodies Cell Cycle Proteins Deoxycytidine Serum Albumin Anti-HIV Agents DNA Primers Transforming Growth Factor beta1 Cystatin C Uric Acid Neoplasm Proteins Antibodies, Antinuclear RNA, Viral Immunoglobulin G RNA, Small Interfering Collagen Type IV Transcription Factors Recombinant Proteins Fluorouracil Erythropoietin Vascular Endothelial Growth Factor A Proto-Oncogene Proteins Pyrimidines Prostate-Specific Antigen Protein-Serine-Threonine Kinases Protein Kinase Inhibitors Angiotensin II Type 1 Receptor Blockers Paclitaxel

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Enzyme Replacement Therapy Glomerular Filtration Rate Blood Pressure Renal Dialysis Treatment Outcome Prognosis Disease Models, Animal Follow-Up Studies Risk Factors Cohort Studies Retrospective Studies Survival Analysis Prospective Studies Kidney Transplantation CD4 Lymphocyte Count Kidney Function Tests Viral Load Survival Rate Immunohistochemistry Severity of Illness Index Predictive Value of Tests Renal Replacement Therapy Kaplan-Meier Estimate Disease-Free Survival Case-Control Studies Proportional Hazards Models Peritoneal Dialysis Longitudinal Studies Antineoplastic Combined Chemotherapy Protocols Biopsy Drug Administration Schedule Neoplasm Staging Nephrectomy Multivariate Analysis Reverse Transcriptase Polymerase Chain Reaction Incidence Risk Assessment Gene Expression Profiling Models, Biological Prevalence Peritoneal Dialysis, Continuous Ambulatory Blotting, Western Sensitivity and Specificity Reproducibility of Results Flow Cytometry Enzyme-Linked Immunosorbent Assay Magnetic Resonance Imaging Polymerase Chain Reaction Reference Values Cross-Sectional Studies Clinical Trials as Topic Blood Urea Nitrogen Drug Therapy, Combination Antiretroviral Therapy, Highly Active Combined Modality Therapy Double-Blind Method Regression Analysis Treatment Failure Oligonucleotide Array Sequence Analysis Infusions, Intravenous Analysis of Variance Administration, Oral Statistics, Nonparametric Randomized Controlled Trials as Topic Immunoenzyme Techniques Arteriovenous Shunt, Surgical Probability

Psychiatry and Psychology2

Alzheimer Disease Huntington Disease

Phenomena and Processes35

Glomerular Filtration Rate Blood Pressure Time Factors CD4 Lymphocyte Count Viral Load Cell Cycle Mutation Cell Proliferation Signal Transduction Gene Expression Regulation, Neoplastic Genotype Phenotype Apoptosis Up-Regulation Sensitivity and Specificity Alleles Cell Division Renin-Angiotensin System Gene Expression Genetic Predisposition to Disease Dose-Response Relationship, Drug Polymorphism, Genetic Gene Expression Regulation Down-Regulation Base Sequence Drug Resistance, Neoplasm Cell Movement Oxidative Stress S Phase Aging Polymorphism, Single Nucleotide Phosphorylation Amino Acid Sequence G1 Phase Probability

Disciplines and Occupations2

Immunohistochemistry Nephrology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science6

Survival Rate Incidence Prevalence Molecular Sequence Data Base Sequence Amino Acid Sequence

Named Groups3

HIV Long-Term Survivors African Continental Ancestry Group European Continental Ancestry Group

Health Care35

Treatment Outcome Follow-Up Studies Risk Factors Cohort Studies Retrospective Studies Survival Analysis Prospective Studies Survival Rate Severity of Illness Index Predictive Value of Tests Kaplan-Meier Estimate Disease-Free Survival Case-Control Studies Proportional Hazards Models Longitudinal Studies Multivariate Analysis Incidence Age Factors Risk Assessment Prevalence Peritoneal Dialysis, Continuous Ambulatory Sensitivity and Specificity Reproducibility of Results Cross-Sectional Studies Comorbidity Clinical Trials as Topic Age of Onset Double-Blind Method Regression Analysis Treatment Failure Analysis of Variance Statistics, Nonparametric Randomized Controlled Trials as Topic Sex Factors Probability

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Disease Progression Kidney Diseases Proteinuria Kidney Failure, Chronic Enzyme Replacement Therapy Kidney Glomerular Filtration Rate Angiotensin-Converting Enzyme Inhibitors Creatinine Blood Pressure Renal Dialysis Diabetic Nephropathies Treatment Outcome Prognosis Time Factors Disease Models, Animal HIV Infections Follow-Up Studies Biological Markers Risk Factors Glomerulonephritis Cohort Studies HIV-1 Retrospective Studies Survival Analysis Renal Insufficiency, Chronic Kidney Glomerulus Prospective Studies Kidney Transplantation CD4 Lymphocyte Count Kidney Function Tests Chronic Disease Viral Load Survival Rate Albuminuria Lupus Nephritis Immunohistochemistry Severity of Illness Index Glomerulosclerosis, Focal Segmental Predictive Value of Tests Prostatic Neoplasms Nephritis Neoplasm Metastasis Renal Replacement Therapy Nephritis, Interstitial Kaplan-Meier Estimate Acquired Immunodeficiency Syndrome Renal Insufficiency AIDS-Associated Nephropathy Cell Line, Tumor Cell Cycle Glomerulonephritis, IGA Nephrology Disease-Free Survival Hypertension, Renal Antineoplastic Agents Case-Control Studies Proportional Hazards Models Mice, Transgenic Nephrosclerosis Mutation Peritoneal Dialysis Cell Proliferation Signal Transduction Mice, Inbred C57BL Longitudinal Studies Antineoplastic Combined Chemotherapy Protocols Fibrosis Tumor Markers, Biological RNA, Messenger Biopsy Gene Expression Regulation, Neoplastic Hypertension Genotype Polycystic Kidney, Autosomal Dominant Uremia Phenotype Drug Administration Schedule Kidney Tubules Polycystic Kidney Diseases Neoplasm Staging Nephrectomy Breast Neoplasms Multivariate Analysis Cells, Cultured Amyotrophic Lateral Sclerosis Reverse Transcriptase Polymerase Chain Reaction Cardiovascular Diseases Incidence CD4-Positive T-Lymphocytes Neoplasms Age Factors Risk Assessment Apoptosis Gene Expression Profiling Models, Biological Prevalence Neoplasm Invasiveness Inflammation Peritoneal Dialysis, Continuous Ambulatory

No FAQ available that match "renal disease progression"